The Low Carb Route to Diabetes Remission
Photo by Farhad Ibrahimzade
eBook Store
⋆
SALE
⋆
eBook Store ⋆ SALE ⋆
Read Time: 2min 17 sec
The battle against type 2 diabetes, a condition that affects millions worldwide, has led to an exploration of various dietary strategies to control and potentially reverse the disease. Among these strategies, low carbohydrate diets (LCDs) have sparked interest due to their promise in managing diabetes effectively. A detailed study published in the BMJ provides a comprehensive analysis of how LCDs and very low carbohydrate diets (VLCDs) fare in achieving diabetes remission, examining their impacts over six months and a year.
Study Overview
This study meticulously reviewed and analyzed data from randomized clinical trials that assessed the effects of LCDs (defined as diets with less than 130 grams of carbs per day or less than 26% of a 2000-calorie diet from carbs) and VLCDs (diets with less than 10% of calories from carbs) on adults diagnosed with type 2 diabetes. The investigation focused on several key outcomes, including the rates of diabetes remission, weight loss, changes in HbA1c levels (a marker of blood sugar control), fasting glucose levels, and any adverse effects resulting from these dietary interventions.
Findings at Six Months
The study's results are particularly striking at the six-month mark:
Diabetes Remission: Participants adhering to LCDs showed a remarkable diabetes remission rate, significantly higher than those following control diets. Specifically, 57% of individuals on LCDs reached a state of remission (HbA1c levels below 6.5%), compared to 31% of those on other diets.
Weight Loss and Triglycerides: Beyond blood sugar control, LCDs were associated with significant weight loss and reductions in triglyceride levels, a type of fat found in the blood, highlighting the diet's broader health benefits.
Insulin Sensitivity: The diet also improved insulin sensitivity, an essential factor in managing diabetes effectively.
Read More: Carbs & Weight Loss: Why Carbohydrates May Be Your Secret Weapon
Long-term Outcomes
While the short-term benefits of LCDs are clear, the long-term outcomes present a more complex picture. By the one-year mark, the pronounced effects on diabetes remission observed at six months appeared to wane, with the study noting a reduction in the magnitude of these benefits over time.
Read More: Diabetes & Weight Loss: A Physician's Guide to Managing Blood Sugar and Shedding Pounds
Quality of Life and Safety
An essential aspect of the study was examining quality of life and safety concerns associated with long-term adherence to LCDs. At six months, there were no significant differences in quality of life metrics. However, by 12 months, there was a noticeable, though not statistically significant, decline in quality of life and an increase in LDL cholesterol levels. Despite these concerns, the study found no significant differences in adverse events or blood lipid levels at six or 12 months, suggesting that LCDs can be safely implemented under proper guidance.
Conclusion
The BMJ study highlights the potential of LCDs in achieving diabetes remission and improving metabolic health markers in the short term without significant adverse effects. These findings support the potential role of LCDs in diabetes management strategies, especially for individuals aiming to reduce their reliance on medications and achieve remission. However, the potential for declines in quality of life and increases in LDL cholesterol levels over time underscores the need for careful monitoring and guidance from healthcare professionals.
For those navigating the challenges of type 2 diabetes, dietary management remains a cornerstone of effective treatment. This study sheds light on the efficacy of LCDs, offering evidence-based guidance for individuals and healthcare providers alike in making informed decisions about diabetes management. As always, any dietary changes should be undertaken with professional advice, ensuring they align with individual health needs and goals.
Article: Goldenberg, Joshua Z et al. “Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data.” BMJ (Clinical research ed.) vol. 372 m4743. 13 Jan. 2021, doi:10.1136/bmj.m4743
